non-adherent

Latitude Study A5359: Long-acting injectable anti-HIV medicine April 30, 2019 The CWRU/UH AIDS Clinical Trials Unit announced today the opening of a new clinical trial for people living with HIV called the Latitude study. The study will be the first in northeast Ohio to use long-acting, injectable anti-HIV medicines. The […]

Latitude Study A5359: Long-acting, injectable ART

April 29, 2019 in News tagged injectable / LA-ART / long-acting / monthly / non-adherent / People Living With HIV by Brooke Willis

Protocol Summary: This study will compare the use of long-acting, injectable anti-HIV medicines with anti-HIV medicines in daily pill form for people living with HIV who have not been previously adherent (keeping up) with their anti-HIV medicines in daily pill form. Purpose of This Study: Anti-HIV medicines taken as pills […]

Latitude A5359: To see if long-acting, injectable ARTs are helpful ...

February 20, 2019 in Clinical Trials / People Living With HIV tagged non-adherent / People Living With HIV by Brooke Willis

Events in November 2024–January 2025

M	T	W	T	F	S	S
28	29	30	31	November 1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	December 1 World AIDS Day (recurring) N/A December 1, 2024 More
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	January 1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31	February 1	2

Case Dental gets $3.25M NIH grant to support research in oral health & HIV

July 13, 2022 9:54 pm

$3.25M NIH grant to support research in oral manifestations of HIV, including mouth cancer Researchers at the Case Western Reserve University School of Dental Medicine will use a $3.25 million grant from the National Institutes of Health (NIH) to better understand how HIV impacts the human body, from mouth lesions to oral... Read more →

A5383: ELICIT clinical trial of anti-CMV medication letermovir

April 22, 2022 6:49 pm

ACTG launches A5383, clinical trial evaluating potential immunologic benefits of treating asymptomatic CMV in people living with HIV The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced the initiation of A5383, a clinical trial evaluating whether the anti- cytomegalovirus (CMV) drug letermovir reduces inflammation when... Read more →

Coronavirus FAQ: What does endemic mean — and are we there yet?

March 12, 2022 6:17 am

Has the pandemic moved into the endemic phase? from NPR’s Goats and Soda It’s been two years since the World Health Organization, on March 11, 2020, officially declared a global pandemic. Since then, we’re all become too familiar with the word pandemic — and sister terms such as epidemic and... Read more →

Breakthrough HIV reported in injectable PrEP trial; experts say drug still very effective

February 23, 2022 4:48 pm

Injectable PrEP highly successful, despite HIV infections Experts say breakthrough HIV should still remain rare in those receiving ViiV Healthcare’s injectable Apretude to prevent infection. In a large clinical trial assessing Apretude, ViiV Healthcare’s recently approved injectable drug, as a form of HIV prevention, seven participants contracted the virus despite... Read more →

NIH’s Dr. Carl Dieffenbach Discusses Highlights of HIV Cure, Treatment and Prevention Research from CROI 2022

February 18, 2022 11:14 pm

CROI2022 overview w/Dr. Carl Dieffenbach, head of NIAID NIAID director Dr. Carl Dieffenbach reviews updates from #CROI2022 (www.croiconference.org) in this 34-minute video. In an HIV.gov video conversation on Wednesday, February 16, NIH’s Dr. Carl Dieffenbach discussed some of the pivotal HIV research advances presented this week at the 2022 virtual... Read more →

Northeast Ohio’s trusted resource for HIV/AIDS Clinical Trials, Primary Care, and World Class Research

Northeast Ohio’s trusted resource for HIV/AIDS Clinical Trials, Primary Care, and World Class Research

non-adherent

Latitude Study A5359: Long-acting, injectable ART

Latitude A5359: To see if long-acting, injectable ARTs are helpful ...

November

December

World AIDS Day (recurring)

January

February